Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches across all sgRNA positions with near-zero ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

The NBDL represents a transition from observing nature as something external to something that is molecularly intimate.

ServerDomes is partnering with Global Green Generation, a global engineering and construction management organization specializing in high-efficiency, AI-ready data center design and delivery, to ...

The bank’s ‘Today, Tomorrow, Forever’ framework helps families organise and navigate their wealth across three interconnected ...

Ansa Biotechnologies Inc., the trusted partner for DNA synthesis, today announced the appointment of Geoff Hamilton as Chief Financial Officer and Chief Business Officer. Mr. Hamilton will report ...

THz communications operate in a largely unused part of the electromagnetic spectrum, where frequencies are measured in ...

Public discussions about AI in PR often focus on the visible parts of the job – quicker idea generation, faster drafting, and ...

Pioneering architect's death marks the end of a chapter in construction innovation, as his digitally driven methods forced ...